The Fidelity Clock

01The evidence

• Translational fidelity and longevity are genetically linked. Manipulating the accuracy of protein synthesis shifts lifespan in model organisms, which places the ribosome in the same pathway as the classical longevity interventions.Nature Communications, 2025
• The obvious version of the story is not supported: codon recognition fidelity of ribosomes at the first and second positions was reported not to decline during aging in rat liver, which argues against a simple global loss of decoding accuracy.Mechanisms of Ageing and Development, 1983

02The tension

Damage-based theories predict that interventions which reduce DNA damage extend life, and they often do not. Meanwhile proteostasis interventions extend life without obviously changing damage. The field has measurements on both sides and no accounting that reconciles them.

03The theory

Distinguish the error rate from the error load. The rate at which a ribosome mistranslates may stay constant, as the 1983 data suggest. What accumulates is the product of that rate and the lifetime of the proteins it produces, plus the failure of chaperones and degradation machinery to keep up.

That accumulated load is self-reinforcing in a mild way. Misfolded proteins titrate chaperones, which raises the misfolding rate for newly synthesised proteins, which adds more load. The loop is not the explosive error catastrophe proposed in the 1960s, because the amplification is weak. It is a slow drift with a positive feedback term, which is exactly the shape of a biological clock.

The model makes an unusual prediction about intervention order. Improving fidelity at the start of life should matter far more than improving it late, because the load is an integral. Conversely, enhancing chaperone capacity late should help even if fidelity is untouched, because it reduces the residence time of the load.

The appealing part is that it unifies dietary restriction, proteasome activators and ribosome accuracy under one quantity that can be measured. The unappealing part is that measuring error load in vivo is hard, which is why the theory has not been settled either way.

04What this is not

05Predictions

• P1A strain engineered for higher translation fidelity should outlive a strain engineered for higher DNA repair, at matched genetic background.
• P2Aggregated misfolding load should predict lifespan across at least ten interventions better than any DNA damage marker.
• P3Methionine restriction should act partly through fidelity, and its benefit should shrink in a fidelity mutant.

06What would refute it

An intervention that raises fidelity, extends life and does not reduce measured error load would break the causal chain and leave the correlation unexplained.

07What it would change

It makes fidelity a geroprotective target and gives aging research a measurable state variable instead of a list of correlated damage types.